Stop paying too much for your prescriptions Thanks for visiting
Based on ICERs reports, semaglutide could be cost-saving (rather than cost-effective) at about $200 per month, and tirzepatide could be cost-saving at about $240 per month
Two 30mg vials cover approximately 5 weeks at 12mg per week, compared to three 20mg vials for the same duration
Clinical research and our clients experiences show improvements in blood sugar levels, even for those without diabetes
This is the first randomized controlled trial of [tirzepatide] and [ixekizumab] in patients with PsA and overweight or obesity that addresses the comprehensive management needs of this patient population, with a positive meaningful impact in multiple domains of PsA disease, including disease control and its comorbidities, Merola and colleagues wrote
3 More recently, a meta-analysis integrating the available trials observed that even doses as low as 80mg twice daily were able to produce significant weight loss as well as reductions in HbA1c
